The mechanism by which pertussis toxin (Ptx) causes lung edema is not clear. We investigated the role of pulmonary manganese superoxide dismutase (MnSOD) and protein kinase C (PKC) in Ptx-induced lung edema. We demonstrated that intraperitoneal injection of Ptx at a concentration of 5 g/100 g body weight caused a similar degree of lung edema in 2 d, as measured by lung wet weight/dry weight ratio, in heterozygous MnSOD gene ( Sod 2)-knockout mice ( Sod 2 ϩ / Ϫ ) and in their wild-type littermates ( Sod 2 ϩ / ϩ ). The level of lung MnSOD activity in Sod 2 ϩ / Ϫ mice was approximately half that of Sod 2 ϩ / Ϫ mice. Ptx had no effect on levels of lung MnSOD messenger RNA, immunoreactive protein, or enzyme activity in either Sod 2 ϩ / ϩ or Sod 2 ϩ / Ϫ mice. Ptx also had no effect on lung copper-zinc SOD, catalase, and glutathione peroxidase activities in these mice. On the other hand, Ptx caused the activation of lung PKC, for example, by translocation of a 72-kD PKC isoform from the cytosolic fraction to the membrane fraction. Pretreatment of mice with bisindolylmaleimide, a PKC inhibitor, prevented both the Ptx-induced activation of PKC and lung edema. These data suggest that Ptx-induced lung edema in mice is, at least in part, due to the activation of lung PKC. Pertussis toxin (Ptx) is an exotoxin produced by Bordetella pertussis , the bacterium that causes whooping cough in humans. In 1957, Andersen (1) reported that intranasal inoculation of the mouse-virulent strain Haemophilus pertussis or its extract caused lung edema in mice. Immunization either with a bacterial vaccine or with the extract of a mouse-virulent strain was unable to protect against lung edema induced by the extract, whereas it protected mice against infection with living organisms and hence prevented lung edema (1). The factor in the bacteria or the extract that causes lung edema is now known to be Ptx. However, the mechanism by which Ptx induces lung edema is not clear.
Pertussis toxin (Ptx) is an exotoxin produced by Bordetella pertussis , the bacterium that causes whooping cough in humans. In 1957, Andersen (1) reported that intranasal inoculation of the mouse-virulent strain Haemophilus pertussis or its extract caused lung edema in mice. Immunization either with a bacterial vaccine or with the extract of a mouse-virulent strain was unable to protect against lung edema induced by the extract, whereas it protected mice against infection with living organisms and hence prevented lung edema (1) . The factor in the bacteria or the extract that causes lung edema is now known to be Ptx. However, the mechanism by which Ptx induces lung edema is not clear.
Recently, Clerch and colleagues (2) reported that intraperitoneal (i.p.) injection of Ptx (5 g/100 g body weight [BW] ) induced lung edema in young rats (21-to 35-d-old) within 12 h. Ptx-induced lung edema was associated with a selective reduction (50%) of pulmonary manganese superoxide dismutase (MnSOD) activity, was attenuated in a hypoxic (15% O 2 ) environment, and was exaggerated by hyperoxic (95% O 2 ) exposure. In addition, enhancing pulmonary MnSOD by endotoxin treatment attenuated Ptxinduced lung edema. It was therefore concluded that Ptxinduced lung edema was due to normoxic O 2 toxicity; for example, a 50% reduction of lung MnSOD activity by Ptx rendered young rats sensitive to O 2 toxicity even at the ambient O 2 concentration (20% O 2 ) (2).
More recently, Patterson and associates (3) reported that Ptx caused a marked increase in albumin permeability of bovine pulmonary artery endothelial cell monolayers, and that the Ptx-induced increase in endothelial permeability was mediated by the activation of protein kinase C (PKC). Activation of PKC by phorbol ester, diacylglycerol, or tumor necrosis factor has been shown to cause increased albumin permeability of endothelial monolayers (4, 5) , as well as lung edema in the isolated, perfused lung (5-7) and in the whole animal (8, 9) . Thus, activation of PKC by Ptx may be one mechanism by which Ptx causes lung edema.
In the current study we investigated the role of pulmonary MnSOD and PKC in Ptx-induced lung edema in mice. We took advantage of the availability of MnSOD gene ( Sod 2)-knockout mice (10, 11) . Our results demonstrated that Ptx had no effect on pulmonary MnSOD in both heterozygous ( Sod 2 ϩ / Ϫ ) mutant mice and their normal ( Sod 2 ϩ / ϩ ) littermates. On the other hand, Ptx activated lung PKC, and inhibition of PKC activation prevented the Ptx-induced lung edema, suggesting that Ptx-induced lung edema in mice is, at least in part, due to PKC activation. 
Materials and Methods

Materials
MnSOD Gene-Knockout Mice
MnSOD gene-knockout mice ( Sod 2 mlucsf ) were obtained by deletion of exon 3 of the Sod 2 gene using targeted homologous inactivation as described by Li and coworkers (10) . Male, heterozygous mutant mice ( Sod 2 ϩ / Ϫ ) backcrossed for six generations (N6) to C57BL/6 mice were obtained from Dr. Charles J. Epstein of the University of California (San Francisco, CA) and were bred with normal C57BL/6J female mice (Jackson Laboratories, Bar Harbor, ME) at the animal research facility of Stratton VA Medical Center, Albany, NY (11) . All cages, bedding, feed, and water were autoclaved, and cages were placed in a ventilated rack.
Genotypes of mutant mice were determined as described previously (11) . Briefly, DNA was obtained by overnight digestion at room temperature of mouse toes with genomic DNA isolation reagent (DNAzol; Molecular Research Center, Inc., Cincinnati, OH) and amplified by polymerase chain reactions (PCRs) of mutant and normal fragments using one shared primer (5 Ј -CGAGGGGCATCTAGTA-GTGGAGAAG-3 Ј ) and one primer for the normal (5 Ј -TTAGGCTCAGGTTGTCCAGAA-3 Ј ) or mutant (5 Ј -CACACATCGGGAAAATGGTTG-3 Ј ) allele. PCR was performed using the following reaction conditions: pre-PCR incubation at 95 Њ C for 5 min followed by 40 cycles of: 95 Њ C, 30 s; 60 Њ C, 30 s; 72 Њ C, 60 s in a 25-l reaction mixture containing DNA (20 to 100 ng), 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 200 M deoxynucleotide triphosphates, 0.125 M primer set, and 0.725 U AmpliTaq Gold DNA polymerase (Perkin-Elmer, Applied Biosystems Division, Foster City, CA), followed by agarose gel electrophoresis. The normal allele produced a ‫ف‬ 500-base pair (bp) band, and the mutant allele produced a ‫ف‬ 350-bp band (10, 11) .
All homozygous mutant ( Sod 2 Ϫ / Ϫ ) mice died within 1 d of birth (11) , whereas the heterozygous mutant ( Sod 2 ϩ / Ϫ ) mice were phenotypically normal (10, 11) . Adult Sod 2 ϩ / Ϫ mice and their normal littermates ( Sod 2 ϩ / ϩ ), 2 to 4 mo old, were used in the current study.
Treatment of Mice
Mice were treated with i.p. injection of 0. 2 ml Hank's balanced salt solution (HBSS) containing various amounts of Ptx (3, 5, or 8 g/100 g BW), or HBSS alone as control. In some experiments, animals were pretreated with tracheal insufflation of 0.05 ml HBSS containing 25 M BIM, or HBSS alone as control, 1 h prior to i.p. injection of Ptx. Briefly, for tracheal insufflation, mice were anesthetized with methoxyflurane and intubated with a 21-gauge intravenous catheter (Angiocath; Becton Dickinson, Sandy, UT) as described previously (12) . HBSS, 50 l, containing 25 M BIM, followed by 100 l of air, was injected into the lungs through the intratracheal catheter. Control mice were injected with 50 l HBSS alone, followed by 100 l of air. Auscultation of the chest with a stethoscope was performed to ensure that the solution was injected into the lungs. Exposure of mice to 100% O 2 was performed as described previously (11) . Mice were given free access to water and food.
Measurement of Lung Edema
At 2 d after i.p. injection of Ptx or O 2 exposure, mice were killed by pentobarbital sodium and exanguinated by transection of the inferior vena cava, and the chest was opened to obtain pleural effusion (PE) for measurement of PE volume. Lungs were removed, trimmed, blotted, and weighed to obtain lung wet weight (ww). They were then placed in a 65 Њ C oven for 2 d and weighed to obtain lung dry weight (dw). The lung ww/dw ratio was then calculated.
Measurement of Pulmonary Antioxidant Enzyme Activities
Preparation of lung extracts for enzyme assays was performed as described previously (11) . Briefly, mice were killed and exanguinated by transection of the inferior vena cava. Lungs were removed, trimmed, blotted, and weighed. The right lung was homogenized using a tissue homogenizer in 0.5 ml potassium phosphate buffer (0.05 M, pH 7.5) containing 1.0 mM ethylenediamenetetraacetic acid (EDTA), sonicated twice for 30 s, and centrifuged at 15,000 ϫ g for 10 min at 4 Њ C. The supernate was then assayed for protein content using bicinchoninic acid according to Smith and associates (13) , and for enzyme activities and MnSOD immunoreactive protein. The left lung was homogenized and washed extensively in perchloric acid (0.5 N) at 4 Њ C; the precipitate was extracted in 1 ml 1.5 N perchloric acid by boiling for 20 min, and assayed for DNA content using the diphenylamine reaction according to Richards (14) .
The SOD activity was assayed using nondenaturing polyacrylamide gel (PAG, 10%) electrophoresis according to Beauchamp and Fridovich (15) , as described previously (11) . The assay was based on the inhibitory effect of SOD on the reduction of tetrazolium by O 2 Ϫ generated by photochemically reduced riboflavin. This method allowed simultaneous visualization and quantification of MnSOD and copper-zinc SOD (CuZnSOD) activities. The SOD activity gel was then quantified using a computing densitometer (Molecular Dynamics, Sunnyvale, CA). In each assay, purified Escherichia coli MnSOD (Sigma; 4,000 U/mg as determined according to McCord and Fridovich [16] ) and bovine erythrocyte CuZnSOD (Sigma; 4,400 U/mg) were used to obtain standard curves from which the lung extract MnSOD and CuZnSOD activities, respectively, were derived. The catalase activity was determined according to Bergmeyer (17) as modified previously (12), and the glutathione (GSH) peroxidase activity was determined according to Paglia and Valentine (18) . The results were expressed as the amount of enzyme activity (units) per milligram DNA to minimize artifacts due to variations in lung size and lung weight (12, 19) , for example, Ptx-induced lung edema.
Immunoblot Analysis of Pulmonary MnSOD
The lung extracts were further analyzed for MnSOD immunoreactive protein using Western blot as described previously (19) . Briefly, lung extracts (30 g protein/lane) were electrophoresed in denaturing sodium dodecyl sulfate (SDS)-PAG (10%) according to Laemmli (20) and transferred electrophoretically to nitrocellulose membrane. The membrane was then blocked with 5% nonfat milk in phosphate-buffered saline plus 0.1% Tween 20, washed, and incubated overnight at 4 Њ C with primary antibody, rabbit antihuman MnSOD (1:1,000). After washing, the membrane was incubated with HRP-labeled secondary antibody, donkey antirabbit IgG (1:1,000) for 1 h, followed by reaction with ECL Western blotting detection reagents according to the manufacturer's instructions (Amersham). The chemiluminescence signal was detected by exposure to X-ray film, quantified using a computing densitometer, and expressed as relative (densitometric) units per milligram DNA.
Northern Blot Analysis of Pulmonary MnSOD Messenger RNA (mRNA)
Northern blot analysis of pulmonary MnSOD mRNA was performed as described previously (19) . Briefly, at 1 d after i.p. injection of Ptx, mice were killed and lungs were removed and extracted for total cellular RNA using an RNeasy Midi Kit (Qiagen, Inc., Santa Clarita, CA).
For Northern blots, denatured RNA samples (15 g/ lane) were electrophoresed in 1.2% agarose-formaldehyde gels, transferred to nylon membrane (Genescreen Plus; New England Nuclear, Boston, MA) by capillary blotting, and stained with methylene blue to visualize the quality and size of 18S and 28S ribosomal RNA species. The membrane was then prehybridized as described previously (19) . Hybridization was carried out with 100 g/ml denatured salmon testis DNA and a murine MnSOD complementary DNA probe that had been labeled by random hexanucleotide priming (GIBCO BRL, Gaithersburg, MD) to a specific activity of Ͼ 10 9 cpm/ g DNA. After washing, autoradiographs were obtained and radioactive signals were quantified using a computing densitometer.
Immunoblot Analysis of Pulmonary PKC
At 2 h after i.p. injection of Ptx or HBSS, mice were killed by i.p. injection of pentobarbital sodium and exanguinated by transection of the inferior vena cava. Lungs and brain were removed and homogenized in 1.0 ml modified radioimmunoprotection assay (RIPA) buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl; 1 mM EDTA; 1 mM 4-[2-aminoethyl] benzene sulfonyl fluoride; 1 mM Na 3 VO 4 ; 1 mM NaF; and 10 g/ml each of aprotinin, leupeptin, and pepstatin) in ice. The homogenates were centrifuged at 2,900 ϫ g for 20 min at 4 Њ C in prechilled centrifuge tubes to remove cell debris and nucleus, followed by centrifugation at 29,000 ϫ g for 45 min at 4 Њ C to obtain the cytosolic fraction. The pellets were resuspended in 0.5 ml ice-cold RIPA buffer containing detergents (1% NP-40 and 0.25% Na deoxycholate) by vortexing for 15 min, followed by centrifugation at 15,000 ϫ g for 20 min at 4 Њ C. The supernates, designated as solubilized membrane fraction, were then stored in aliquots at Ϫ 70 Њ C.
Immunoblotting was performed as described previously. Briefly, cytosolic and membrane fractions, 10 g protein/ lane, were electrophoresed in denaturing SDS-PAG (10%), transferred to nitrocellulose membrane, blocked, washed, and incubated with primary antibody, mouse monoclonal anti-PKC (1:1,000 dilution), for 1 h at room temperature. After washing, the membrane was incubated with HRPlabeled secondary antibody, sheep antimouse IgG (1:2,000 dilution) for 1 h, followed by reactions with ECL Western blotting detection reagents. The chemiluminescent signal Figure 1 . Effect of Ptx on lung ww/dw ratio of Sod2 ϩ/ϩ mice. Adult mice were treated with i.p. injection of Ptx (3, 5, or 8 g/ 100 g BW) in 0.2 ml HBSS, or HBSS alone as control. Two days later, lung ww/dw ratio was determined. Results are expressed as means Ϯ SE. n ϭ 5 animals in each group. *P value (versus control) Ͻ 0.005. was detected by exposure to X-ray film and quantified using a computing densitometer.
Statistical Analysis
Data from two groups were compared by a two-tailed t test, and those from more than two groups were compared by one-way analysis of variance with Bonferroni's correction for multiple comparisons (21), using a commercially available statistical analysis program (SPSS Inc., Arlington, VA). Differences were considered significant at P Ͻ 0.05.
Results
Ptx-Induced Lung Edema
Injection of Ptx i.p. caused a dose (3 to 8 g/100 g BW)-dependent increase in lung ww/dw ratio, an index of lung edema, in normal (Sod2 ϩ/ϩ ) mice (Figure 1 
ϩ/ϩ mice in our study were 5.03 Ϯ 0.10 and 4.44 Ϯ 0.10 (n ϭ 5 in each group), respectively (Figure 1) .
To assess the role of pulmonary MnSOD in Ptx-induced lung edema, we first examined the effect of Ptx in heterozygous Sod2-knockout mice (Sod2 ϩ/Ϫ ), which we have previously shown to have approximately 50% pulmonary MnSOD activity as compared with their normal littermates (Sod2 ϩ/ϩ ) (11). As shown in Figure 2 , i.p. injection of 5 g/100 g BW Ptx also caused lung edema, (e.g., an increase in lung ww/dw ratio) in Sod2 ϩ/Ϫ mice (P value, Sod2 ϩ/Ϫ Ptx versus Sod2 ϩ/Ϫ control, P Ͻ 0.005). However, there was no difference between Sod2 ϩ/ϩ and Sod2 ϩ/Ϫ mice. Also shown in Figure 2 is the effect of hyperoxia on lung ww/dw ratio in Sod2 ϩ/ϩ and Sod2 ϩ/Ϫ mice. Exposure of mice to 100% O 2 for 2 d caused only a slight increase in lung ww/dw ratio, and there was no difference between Sod2 ϩ/ϩ and Sod2 ϩ/Ϫ mice, consistent with our previous observation that Sod2 ϩ/Ϫ mice were not more susceptible to pulmonary O 2 toxicity than were Sod2 ϩ/ϩ mice (11). It is evident that 5 g/100 g BW of Ptx appeared to cause more lung edema in mice than 2 d of 100% O 2 exposure. All subsequent experiments were performed using 5 g Ptx/ 100 g BW.
Effect of Ptx on Pulmonary Antioxidant Enzyme Activities
Clerch and coworkers (2) reported that i.p. injection of Ptx in young (21-to 35-d-old) rats selectively reduced pulmonary MnSOD activity that was thought to be responsible for Ptx-induced lung edema. Therefore, we determined the effect of Ptx on pulmonary MnSOD and CuZnSOD and Sod2 ϩ/Ϫ mice. Adult mice were treated with i.p. injection of Ptx (5 g/100 g BW) in 0.2 ml HBSS, or HBSS alone as control. Two days later, lung extracts were assayed for SOD activities using nondenaturing PAGE followed by SOD activity staining. For lung MnSOD activity (A), 200 g protein/lane was used and the assay was performed in the presence of 5 mM KCN to partially inhibit CuZnSOD activity. For CuZnSOD activity (B), 12.5 g protein/lane was used. Each lane (lanes 1-8) represents the result of one animal. A total of 18 mice were studied; however, the results of only eight mice (two from each group) are presented in this figure. Lanes 1 and 2 activities in mice. This was performed using SOD activity gels that allowed simultaneous visualization and quantification of MnSOD and CuZnSOD activities.
As shown in Figure 3 , mouse MnSOD and CuZnSOD could be readily separated using PAG electrophoresis (PAGE). Note that we used purified E. coli MnSOD and bovine erythrocyte CuZnSOD, which migrated to different positions from those of mouse enzymes (11), to construct standard curves for the purpose of densitometric quantification of mouse SOD activities. Because lung CuZnSOD activity was much higher than that of MnSOD, for the quantification of MnSOD activities, 200 g protein per lane was used in the presence of 5 mM KCN to inhibit partially the activities of CuZnSOD ( Figure 3A ). For lung CuZnSOD activity, a separate gel using 12.5 g protein per lane was used ( Figure 3B ). It is obvious that Sod2 ϩ/Ϫ mice had reduced lung MnSOD activities ( Figure 3A) , whereas CuZnSOD activities were comparable to those of
Sod2
ϩ/ϩ mice ( Figure 3B ). In addition, Ptx had no effect on MnSOD or CuZnSOD activities in either Sod2 ϩ/ϩ or Sod2 ϩ/Ϫ mice. Figure 4 summarizes the results of pulmonary antioxidant enzyme activities in mice treated with or without Ptx. As expected, lung MnSOD activities in Sod2 ϩ/Ϫ mice were approximately half those of Sod2 ϩ/ϩ mice, whereas CuZn-SOD, catalase, and GSH peroxidase activities were similar in both groups. At 2 d after injection, Ptx had no effect on MnSOD, CuZnSOD, catalase and GSH peroxidase activities in either Sod2 ϩ/ϩ or Sod2 ϩ/Ϫ mice.
Effect of Ptx on Pulmonary MnSOD Immunoreactive Protein and mRNA
The effect of Ptx on lung MnSOD was further studied using immunoblot and Northern blot analyses. As shown in Figure 5 , the level of MnSOD immunoreactive protein in Sod2 ϩ/Ϫ mutants was reduced compared with that of Sod2 ϩ/ϩ mice. Furthermore, Ptx had no effect on the level of lung MnSOD immunoreactive protein in either Sod2
or Sod2 ϩ/Ϫ mice. These data were consistent with the re- sults for MnSOD enzyme activity as shown in Figures 3  and 4 .
Northern blot analysis revealed that the level of lung MnSOD mRNA, expressed as MnSOD mRNA/18S RNA ratio, in Sod2 ϩ/Ϫ mutants was similar to that of wild-type Sod2 ϩ/ϩ mice. Furthermore, Ptx had no effect on the level of pulmonary MnSOD mRNA in either Sod2 ϩ/ϩ or Sod2 ϩ/Ϫ mice ( Figure 6 ). The observation that Sod2 ϩ/Ϫ mutants had levels of lung MnSOD mRNA similar to that of Sod2 ϩ/ϩ mice, whereas levels of MnSOD immunoreactive protein and enzyme activity were significantly lower in Sod2 ϩ/Ϫ mice than in Sod2 ϩ/ϩ mice, was surprising. The most likely explanation is that in this MnSOD gene-knockout mutant, the mutant MnSOD gene is transcribed but the mutant mRNA is nonfunctional, resulting in no MnSOD immunoreactive protein or enzyme activity. The murine MnSOD gene consists of five exons, and in this knockout mutant (Sod2 mlucsf ) exon 3, which encodes 39 amino acids involved in homodimerization, tetramer formation, and manganese binding, was deleted (10) . As shown in Figure 6A , we were unable to distinguish mutant MnSOD mRNA from normal mRNA by the size difference in Northern blotting, likely due to polyadenydation of the MnSOD mRNA (22) . To confirm this possibility, Northern blot of RNA extract from fetal heart of one homozygous Sod2 Ϫ/Ϫ mutant revealed abundant MnSOD mRNA, whereas no MnSOD immunoreactive protein or enzyme activity in the myocardial extract of Sod2 Ϫ/Ϫ mutant was detectable in the immunoblot and activity gel, respectively (data not shown).
Role of PKC in Ptx-Induced Lung Edema
Because Ptx had no effect on mouse lung MnSOD, we next examined the role of PKC activation in Ptx-induced lung edema. Because Sod2 ϩ/ϩ and Sod2 ϩ/Ϫ mice showed similar responses to Ptx, we pooled the data from these two groups together in this study. We used the PKC inhibitor BIM, which blocks the adenosine triphosphate-binding domain and thus inhibits all PKC isotypes (23) . BIM was given by tracheal insufflation 1 h prior to i.p. injection of Ptx. As shown in Figure 7 , BIM alone had no effect on lung ww/dw ratio. However, it completely abolished the Ptx-induced increase in lung ww/dw ratio, suggesting that Ptx-induced lung edema might be mediated by PKC activation.
Activation of lung PKC by Ptx was further confirmed by immunoblotting of lung cytosolic and membrane fractions. The PKC antibody used was a mouse monoclonal antibody raised against purified bovine brain PKC. This antibody recognizes an epitope located within the amino acid sequence 296-317, at the hinge region close to or at the trypsin cleavage site of PKC (24) , and is known to cross-react with mouse PKC. As shown in Figures 8A and  8B , two bands of immunoreactive proteins were noted in control mouse lung (approximately 80 and 72 kD) (lanes 1  and 2) and brain (approximately 80 and 38 kD) (lane 9) . In the lung cytosolic fraction (Figure 8A ), only the 72-kD band was noted. In contrast, the 80-kD band was the dominant band in the membrane fraction ( Figure 8B ). On the other hand, in brain the 80-kD band was the dominant protein in both cytosolic and membrane fractions.
At 2 h after i.p. injection of Ptx, there was a shift of 72-kD PKC from the cytosolic fraction to the membrane fraction ( Figures 8A and 8B, lanes 3 and 4) as compared with controls (lanes 1 and 2) , suggesting activation of PKC. The membrane-to-cytosol (M/C) ratio of the 72-kD band increased from 0.6 in the control group to 1.7 in the Ptxtreated group ( Figure 8C) . Pretreatment with BIM increased the 72-kD band in the cytosolic fraction ( Figures  8A and 8B, lanes 5 and 6) , resulting in a reduced M/C ratio. On the other hand, pretreatment of BIM abolished Ptx-induced translocation of 72-kD PKC from the cytosolic fraction to the membrane fraction (lanes 7 and 8) .
Discussion
The results presented in the current study demonstrated that Ptx: (1) caused a similar degree of lung edema in Sod2 ϩ/ϩ and Sod2 ϩ/Ϫ mice; (2) had no effect on pulmonary antioxidant enzyme activities, including MnSOD; and (3) activated lung PKC. Furthermore, prevention of lung PKC activation by a PKC inhibitor, BIM, abolished Ptx-induced lung edema. These results suggest that Ptx-induced lung edema in mice is, at least in part, due to PKC activation.
Clerch and associates (2) reported that Ptx, while stimulating the steady-state level of pulmonary MnSOD mRNA, inhibited the enzyme activity. We were unable to demonstrate any effect of Ptx on the levels of pulmonary MnSOD mRNA, immunoreactive protein, or enzyme activity. The reason for the discrepancy between the current study and that of Clerch and coworkers (2) is not clear. It could be due to species differences. Clerch and associates used young (21-to 35-d-old) rats, while we used 2 to 4-mo-old Sod2 ϩ/ϩ and Sod2 ϩ/Ϫ mice. In addition, the methods used for assaying SOD activity were different. In the current study, we used an SOD activity gel, which allowed direct quantification of MnSOD and CuZnSOD activities individually after separation of the enzymes by PAGE. On the other hand, in the study of Clerch and colleagues (2), MnSOD activity was assayed in the presence of diethyldithiocarbamate (DDC) to inhibit the activity of CuZnSOD (25) in a whole-lung extract using the ferricytochrome c reduction method. Thus, the accuracy of MnSOD activity measurement is dependent on the complete and selective inhibition of CuZnSOD activity by the concentration of DDC used. In lung tissue, CuZnSOD constitutes the majority of SOD, so any residual CuZnSOD activity will profoundly affect the measured MnSOD activity. Unfortunately, the assay itself does not allow investigators to ascertain whether all CuZnSOD activity has, in fact, been completely and selectively inhibited by DDC. Whether this difference in methodologies for the SOD assay accounts for the observed difference in the effect of Ptx on lung MnSOD is not clear.
The recent availability of SOD gene-knockout mice has provided valuable insight into the role of various SOD isozymes in the host defense against O 2 toxicity. Despite being the major cellular SOD, homozygous CuZnSOD gene-knockout mice (Sod1 Ϫ/Ϫ ) with no CuZnSOD activity develop and survive normally for months in room air with no apparent abnormalities (26) . Furthermore, they are no more susceptible to 100% O 2 toxicity than are their wildtype (Sod1 ϩ/ϩ ) littermates (27) . Likewise, homozygous ex- ) are phenotypically normal in room air; however, when exposed to a lethal dose of O 2 (Ͼ 95%), they develop severe lung injury earlier and have a shorter survival than their wildtype (Sod3 ϩ/ϩ ) littermates (28) . In contrast, homozygous MnSOD gene-knockout mice (Sod2 Ϫ/Ϫ ) die shortly after birth in room air, with extensive mitochondrial injury and dilated cardiomyopathy (10, 29) . How long they survive depends on the genetic background; for example, Sod2 Ϫ/Ϫ mutant mice on a CD-1 background die within 10 d (10); on a C57BL/6J background (the one used in the current study), they die within 1 d after birth (11) ; and on a mixed background, they survive up to 18 d (29). Li and colleagues (10) reported that at 4 to 5 d after birth, the lung water content of Sod2 Ϫ/Ϫ mice (on a CD-1 background) was similar to that of normal Sod2 ϩ/ϩ littermates, suggesting that in mice with no MnSOD activity there was no evidence of lung edema even after 4 to 5 d of exposure to room air (20% O 2 ). We have demonstrated that there is no increase in the susceptibility of Sod2 ϩ/Ϫ mice with 50% of normal lung MnSOD activity to hyperoxia (e.g., 100% O 2 ) as compared with their Sod2 ϩ/ϩ littermates (11). These observations are in marked contrast to the conclusion by Clerch and coworkers (2) that a 50% reduction of lung MnSOD activity in 21-to 35-d-old rats rendered them susceptible to room air O 2 toxicity with lung edema developing within 2 d. Whether this is due to species differences needs further investigation.
Our observation that Ptx activated lung PKC and that inhibition of PKC activation prevented Ptx-induced lung edema suggests that Ptx-induced lung edema in mice is mediated through PKC activation. This is consistent with the report of Patterson and coworkers (3), who demonstrated that Ptx-induced increase in albumin permeability of cultured bovine pulmonary endothelial cell monolayers was due to PKC activation. The mechanism by which Ptx activates PKC is not clear. Ptx is a hexameric protein with typical AB architecture, consisting of an A protomer (S1) and a B oligomer (S2, S3, two S4's, and S5) (30) . The A protomer has adenosine diphosphate (ADP)-ribosyltransferase activity, which catalyzes the transfer of ADP-ribose from nicotinamide adenine dinucleotide to a regulatory guanosine triphosphate-binding protein (G protein) in eukaryotic cells (31) . The B oligomer also has some biologic activities (independent of the enzymatic activity of the A protomer), such as the activation of platelets and mitogenicity for lymphocytes (30, 32) . Through ADP-ribosylation, Ptx inactivates a subclass (␣ i ) of heterotrimeric G proteins involved in transmembrane signal transduction. Some of the functions of ␣ i subclass G proteins are the inhibition of adenylyl cyclase, the regulation of K ϩ and Ca 2ϩ channels, and the activation of cyclic guanosine monophosphate phosphodiesterase (31, 33) . Whether Ptx-induced activation of PKC, as demonstrated in the current study and that of Patterson and colleagues (3) , is mediated through ADP-ribosylation and inactivation of G-proteins is not clear. Ptx has been used extensively as a powerful tool to selectively inhibit G␣ i proteins in studying signal transduction pathways (31, 33) . The demonstration that Ptx can activate PKC, leading to impaired endothelial barrier function and lung edema, raises the important question of the specificity and interpretation of results obtained when Ptx is used to inhibit G proteins.
In the current study we used a broad-spectrum PKC inhibitor, BIM, that inhibits all PKC isotypes (22) . Likewise, the PKC monoclonal antibody used reacts with a number of PKC isotypes (24 and current study). Thus, we were unable to determine which PKC isotype(s) was activated by Ptx. However, we noticed that the molecular weight of the Ptx-sensitive PKC was approximately 72 kD. Further studies are necessary to identify the PKC isotype that is activated by Ptx, and the mechanism by which Ptx activates PKC.
